Status:

COMPLETED

A New Membrane Obturator Prothesis Concept for Soft Palate Defects

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Mouth Neoplasms

Velopharyngeal Insufficiency

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

When soft palate defects lead to palatal insufficiency, the patient's quality of life is affected by difficulties swallowing, hypernasality, and poor intelligibility of speech. If immediate surgical r...

Detailed Description

The velopharyngeal sphincter seals the oropharynx from the nasopharynx during swallowing and speech. This three-dimensional muscular valve closes through the synergistic behavior of the soft palate an...

Eligibility Criteria

Inclusion

  • Adult over 18 year-old
  • Acquired loss of velar or palato-velar substance (maxillectomies of Class I and II a-d, Brown 2010) following the excision of a tumor
  • Indication of Suersen obturator prosthesis rehabilitation
  • Possible dental rehabilitation with removable prosthesis (retention and stability prosthetic provided without the use of glue, mouth opening allowing fingerprints, presence of saliva, dexterity allowing the insertion and removal of prostheses, as well as the cleaning of devices)
  • Having given their consent to participate in the study
  • Speaking French, knowing how to read it
  • Available and motivated for regular follow-up during the study period

Exclusion

  • Child under 18
  • Allergy to acrylic resin
  • Radiotherapy or chemotherapy in progress
  • Surgery of the veil programmed during the 3 months necessary for the realization and the wearing of the prostheses.
  • Loss of congenital or traumatic palato-velar substance
  • Maxillectomies including orbital floor or total maxillectomy
  • Pregnant or lactating woman
  • Participation in another interventional study
  • Inability to give informed consent

Key Trial Info

Start Date :

July 17 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2022

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT04009811

Start Date

July 17 2020

End Date

July 15 2022

Last Update

February 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Bordeaux

Bordeaux, France, 33076